Bristol Myers Squibb BMY
NYSE BMY
$62.93 -0.50 (-0.79%)
At close: Nov 16, 2026 · 4:00 PM EST

Bristol Myers Squibb (BMY) Depreciation & Amortization (CF) (2009 - 2026)

Updated

Bristol Myers Squibb (BMY) reported Depreciation & Amortization (CF) of $626 million for Q3 2026, down 38.1% from $1.01 billion a year earlier but up 5.4% from the prior quarter.

Analysis

Bristol Myers Squibb (BMY) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Bristol Myers Squibb's Depreciation & Amortization (CF) came in at $2.79 billion, down 43.2% year-over-year; for FY2025, it came in at $4.01 billion, down 58.2% from FY2024.

  • Depreciation & Amortization (CF) has declined for four consecutive years, with a five-year compound annual growth rate of -17.3% (FY2020 to FY2025).
  • By year, Depreciation & Amortization (CF) came in at $9.6 billion in FY2024 (-1.6%), $9.76 billion in FY2023 (-5.0%), $10.28 billion in FY2022 (-3.8%) and $10.69 billion in FY2021 (+2.9%).
  • Five-year quarterly Depreciation & Amortization (CF) spans a low of $594 million in Q1 2026 and a high of $2.6 billion in Q2 2024.
  • Year over year, Depreciation & Amortization (CF) has now declined in each of the last eight quarters, with an average decline of 46.8% over the last eight quarters.
  • The high point for year-over-year Depreciation & Amortization (CF) in five years was Q2 2024 (growth of 6.7%); the low point was Q2 2025 (a decline of 61.1%).
  • Per Business Quant data, the three quarters before Q3 2026 came in at $594 million (Q2 2026), $594 million (Q1 2026) and $977 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 2.12 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 192.00 Mn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 1.61 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 132.00 Mn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 1.58 Bn
10 Bristol Myers Squibb 128.63 Bn 83.82 Bn 8.92 Bn 626.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 626.00 Mn
Jun 30, 2026 594.00 Mn
Mar 31, 2026 594.00 Mn
Dec 31, 2025 977.00 Mn
Sep 30, 2025 1.01 Bn
Jun 30, 2025 1.01 Bn
Mar 31, 2025 1.01 Bn
Dec 31, 2024 1.88 Bn
Sep 30, 2024 2.59 Bn
Jun 30, 2024 2.60 Bn
Mar 31, 2024 2.53 Bn
Dec 31, 2023 2.46 Bn
Sep 30, 2023 2.44 Bn
Jun 30, 2023 2.43 Bn
Mar 31, 2023 2.43 Bn
Dec 31, 2022 2.52 Bn
Sep 30, 2022 2.59 Bn
Jun 30, 2022 2.58 Bn
Mar 31, 2022 2.58 Bn
Dec 31, 2021 2.58 Bn
API Access

Bristol Myers Squibb Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=BMY&period=max&api_key=YOUR_API_KEY